Related Experiment Videos
Gene amplification and altered enzymes as mechanisms for the development of drug resistance
Abstract:
Two known mechanisms by which neoplastic cells may become resistant to chemotherapeutic agents are reviewed, using methotrexate (MTX) resistance as a model. These mechanisms are an increased level of target enzyme, found in several instances to be a consequence of gene amplification, or an altered target enzyme or receptor, less capable of binding the drug. An example of MTX resistance due to low-level gene amplification in leukemia cells from an MTX-resistant patient is described. Strategies for selectively eradicating these resistant cell populations may be formulated based on the mechanism by which these cells became drug-resistant.
Insights
Neoplastic cells develop chemotherapy resistance through increased target enzymes or altered drug-binding sites. Understanding these mechanisms, like methotrexate resistance via gene amplification in leukemia, aids in developing targeted therapies.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Chemotherapeutic resistance in neoplastic cells is a major challenge in cancer treatment.
- Two primary mechanisms contribute to drug resistance: altered drug targets and increased drug metabolism or efflux.
- Methotrexate (MTX) resistance serves as a well-studied model for understanding these phenomena.
Purpose of the Study:
- To review the known mechanisms of neoplastic cell resistance to chemotherapeutic agents.
- To illustrate these mechanisms using methotrexate resistance as a model.
- To describe a specific case of MTX resistance in leukemia cells due to gene amplification.
Main Methods:
- Literature review of established mechanisms of drug resistance.
- Analysis of gene amplification as a cause for increased target enzyme levels.
- Case study description of methotrexate-resistant leukemia cells.
Main Results:
- Neoplastic cells can develop resistance by increasing the level of their target enzyme, often via gene amplification.
- Alternatively, resistance can arise from alterations in the target enzyme or receptor, reducing drug binding affinity.
- A specific instance of low-level gene amplification conferring MTX resistance in leukemia cells was observed.
Conclusions:
- Understanding the specific mechanism of drug resistance is crucial for effective cancer therapy.
- Targeted strategies can be developed to eliminate drug-resistant cancer cell populations.
- Further research into resistance mechanisms can lead to improved chemotherapeutic approaches.